Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity

Mol Pharmacol. 2009 Feb;75(2):318-23. doi: 10.1124/mol.108.049486. Epub 2008 Nov 5.

Abstract

Enhancing cocaine metabolism by administration of cocaine esterase (CocE) has been recognized as a promising treatment strategy for cocaine overdose and addiction, because CocE is the most efficient native enzyme for metabolizing the naturally occurring cocaine yet identified. A major obstacle to the clinical application of CocE is the thermoinstability of native CocE with a half-life of only a few minutes at physiological temperature (37 degrees C). Here we report thermostable variants of CocE developed through rational design using a novel computational approach followed by in vitro and in vivo studies. This integrated computational-experimental effort has yielded a CocE variant with a approximately 30-fold increase in plasma half-life both in vitro and in vivo. The novel design strategy can be used to develop thermostable mutants of any protein.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Carboxylic Ester Hydrolases / metabolism
  • Carboxylic Ester Hydrolases / therapeutic use*
  • Cocaine / administration & dosage
  • Cocaine / metabolism*
  • Cocaine / toxicity
  • Cocaine-Related Disorders / complications
  • Cocaine-Related Disorders / drug therapy*
  • Disease Models, Animal
  • Drug Design
  • Drug Overdose
  • Male
  • Mice
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Carboxylic Ester Hydrolases
  • cocaine esterase
  • Cocaine